- Tytuł:
- Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)
- Autorzy:
- Źródło:
- Arthritis & Rheumatology. Dec2023, p1. 14p. 8 Illustrations.
Czasopismo naukowe